ArticleEuropean radiology2026
Development of a quantitative multiparametric ultrasound and deep learning classifier for the detection of prostate cancer.
Article in European radiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Multiparametric Abdominal Ultrasound as a Source of Imaging Biomarkers in Predictive and Personalized Medicine: A Narrative Review.Diagnostics (Basel, Switzerland) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
objectivesProstate cancer (PCa) diagnosis is increasingly guided by imaging, with ultrasound (US) emerging as a cost-effective and widely accessible modality. This study develops a deep learning-based classifier predicting the presence of clinically significant (cs)PCa using quantitative features extracted from 3D multiparametric (mp)US. MATERIALS AND
methodsA multicenter prospective cohort of 327 patients with suspicion of PCa underwent transrectal 3D mpUS scanning, including dynamic contrast-enhanced US and shear-wave elastography. Acquisitions were registered to 3D histology from radical prostatectomy, which served as the reference standard for the presence of csPCa. Voxels within lesions with International Society of Urological Pathology (ISUP) Grade Group ≥ 2 were considered malignant, and the rest were benign. A 3D deep learning classifier was trained on quantitative mpUS features to detect csPCa. The classifier was trained and internally evaluated on 250 patients and externally evaluated on 77 patients acquired later. Classifier performance was evaluated per voxel using the area under the receiver operating characteristic curve (ROC AUC).
resultsUsing quantitative mpUS features from 327 patients, the classifier achieved a ROC AUC of 0.87 (95% CI: 0.85-0.89) on the internal evaluation set, using 7-fold cross-validation. On the external evaluation cohort, the classifier achieved a ROC AUC of 0.88 (95% CI: 0.87-0.89).
conclusionThe proposed classifier accurately detects csPCa using quantitative features from 3D mpUS and generalizes well to the external dataset. These results support mpUS as a promising, cost-effective tool for csPCa diagnosis. KEY POINTS: Question: Can quantitative features extracted from 3D multiparametric ultrasound (mpUS) reliably detect clinically significant prostate cancer (csPCa), enabling more accessible and affordable diagnosis?
findingsPredicting csPCa using quantitative multiparametric ultrasound features achieved an area under the receiver operating characteristic curve of 0.87, increasing to 0.88 when externally evaluated. CLINICAL RELEVANCE: Our proposed deep learning-based classifier using quantitative 3D mpUS features accurately detects csPCa, as validated on the largest mpUS prostate dataset to date. This opens the door to ultrasound as an accurate, cost-effective method for csPCa detection.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.